🇺🇸 FDA
Patent

US 11529312

Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use

granted A61KA61K2039/55555A61K2039/58

Quick answer

US patent 11529312 (Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/55555, A61K2039/58, A61K31/6615, A61K31/685